NLSP NLS Pharmaceutics
- 0.1903
- -0.0059-3.01%
NLS Pharmaceutics News
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
20-F: Registration statement / Annual report / Transition report
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 20-F: FY2022 Annual Report
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
NLS Pharmaceutics | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
